$3.06T
Total marketcap
$94.56B
Total volume
BTC 57.65%     ETH 11.66%
Dominance

ENDRA Life Sciences NDRA Stock

$5.10   0.000000%
Add to favorites
Market Cap
$5.95M
LOW - HIGH [24H]
$5.00 - $5.10
VOLUME [24H]
$5.48K
P/E Ratio
0.26
Earnings per share
$19.52
Price   Prediction

ENDRA Life Sciences Price Chart

Sorry, that's all we've gotfor now...

ENDRA Life Sciences NDRA Financial and Trading Overview

ENDRA Life Sciences stock price 5.1 USD
Previous Close 7.45 USD
Open 7.5 USD
Bid 5.46 USD x 200
Ask 8.97 USD x 200
Day's Range 7.01 - 7.71 USD
52 Week Range 2.9 - 168 USD
Volume 56.13K USD
Avg. Volume 1.74M USD
Market Cap 5.36M USD
Beta (5Y Monthly) -0.217
PE Ratio (TTM) 0.01821997
EPS (TTM) 19.52 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 46 USD

NDRA Valuation Measures

Enterprise Value 1.11M USD
Trailing P/E 0.01821997
Forward P/E -0.022831488
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 2.283515
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.118

Trading Information

ENDRA Life Sciences Stock Price History

Beta (5Y Monthly) -0.217
52-Week Change -94.91%
S&P500 52-Week Change 13.16%
52 Week High 168 USD
52 Week Low 2.9 USD
50-Day Moving Average 4.28 USD
200-Day Moving Average 5.24 USD

NDRA Share Statistics

Avg. Volume (3 month) 1.74M USD
Avg. Daily Volume (10-Days) 9.88M USD
Shares Outstanding 752.76K
Float 738.28K
Short Ratio 0.4
% Held by Insiders 0.10%
% Held by Institutions 0.15%
Shares Short 16.94K
Short % of Float 2.29%
Short % of Shares Outstanding 2.29%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:35

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2024
Most Recent Quarter (mrq) March 31, 2025
Next Fiscal Year End December 31, 2025

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -144.35%
Return on Equity (ttm) -358.40%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -9460913 USD
Net Income Avi to Common (ttm) -9768577 USD
Diluted EPS (ttm) 390.78
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.06M USD
Total Cash Per Share (mrq) 2.8 USD
Total Debt (mrq) 587.3K USD
Total Debt/Equity (mrq) 33.51 USD
Current Ratio (mrq) 3.853
Book Value Per Share (mrq) 3.118

Cash Flow Statement

Operating Cash Flow (ttm) -6549364 USD
Levered Free Cash Flow (ttm) -5901238 USD

Profile of ENDRA Life Sciences

Country United States
State MI
City Ann Arbor
Address 3600 Green Court
ZIP 48105-1570
Phone 734 335 0468
Website https://endrainc.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 21

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Q&A For ENDRA Life Sciences Stock

What is a current NDRA stock price?

ENDRA Life Sciences NDRA stock price today per share is 5.1 USD.

How to purchase ENDRA Life Sciences stock?

You can buy NDRA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ENDRA Life Sciences?

The stock symbol or ticker of ENDRA Life Sciences is NDRA.

Which industry does the ENDRA Life Sciences company belong to?

The ENDRA Life Sciences industry is Diagnostics & Research.

How many shares does ENDRA Life Sciences have in circulation?

The max supply of ENDRA Life Sciences shares is 1.17M.

What is ENDRA Life Sciences Price to Earnings Ratio (PE Ratio)?

ENDRA Life Sciences PE Ratio is 0.26127050 now.

What was ENDRA Life Sciences earnings per share over the trailing 12 months (TTM)?

ENDRA Life Sciences EPS is 19.52 USD over the trailing 12 months.

Which sector does the ENDRA Life Sciences company belong to?

The ENDRA Life Sciences sector is Healthcare.

ENDRA Life Sciences NDRA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
US Tech Composite IXIC 23651.32 USD
+0.16
630.48M USD 23610.19 USD 23663.6 USD 630.48M USD
US Tech Capital Market Composite RCMP 131.29 USD
-1.33
131.24 USD 132.71 USD
US Tech Health Care IXHC 1208.21 USD
-0.32
1207.76 USD 1210.54 USD
✨New! Portfolio🚀